Summary:
A PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RTA 901 IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN
Criteria:- At least 18 years of age
- Diagnosed with type 1 diabetes mellitus or type 2 diabetes mellitus at least 1 year prior to screening
- Diagnosed with DPNP
Qualified Participants May Receive:
- Compensation for time and travel.
- Study-related care at no cost